skip to content

03 - 05 Sept 2017 Cambridge, UK


 Dr Philipp Selenko

 FMP Berlin, Germany​





Phil studied Chemistry and Biochemistry at the University of Vienna. He completed his PhD in biomolecular NMR spectroscopy at the EMBL in Heidelberg (with Michael Sattler) before joining Gerhard Wagner’s lab at Harvard Medical School for his PostDoc (2003-2008). There, he started using NMR spectroscopy for studying proteins directly in live cells at atomic resolution. At Harvard, developed the first eukaryotic model system for in-cell NMR spectroscopy. Since 2008, he runs the in-cell NMR group at the FMP in Berlin. His laboratory investigates how cell signaling and post-translational modifications affect protein structure and function, and how intracellular amyloid proteins change their conformations at the onset of human neurodegenerative diseases. To this end, they employ cellular systems ranging from immortalized cell lines to patient-derived induced pluripotent stem cells differentiated into specific neuronal lineages. Phil and his lab will move to the Weizmann Institute of Science in 2018.